ESPR icon

Esperion Therapeutics

136 hedge funds and large institutions have $352M invested in Esperion Therapeutics in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

5.14% more ownership

Funds ownership: 82.66%87.8% (+5.1%)

3% more funds holding

Funds holding: 132136 (+4)

0% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 42

Holders
136
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14.4M
Puts
$2.78M
Net Calls
Net Calls Change

Top Buyers

1 +$13.1M
2 +$9.27M
3 +$6.76M
4
WP
Woodline Partners
California
+$5.37M
5
BlackRock
BlackRock
New York
+$3.37M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$330K
52
$306K
53
$304K
54
$300K
55
$296K
56
$292K
57
$286K
58
$273K
59
$234K
60
$212K
61
$210K
62
$206K
63
$195K
64
$190K
65
$189K
66
$188K
67
$178K
68
$172K
69
$169K
70
$169K
71
$161K
72
$155K
73
$154K
74
$153K
75
$141K